β Fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction: The ECTIM study

Circulation

Volumn 93, Issue 3, 1996, Pages 440-449

  Behague, Isabelle ^a   Poirier, Odette ^a   Nicaud, Viviane ^a   Evans, Alun ^b   Arveiler, Dominique ^c   Luc, Gérald ^c   Cambou, Jean Pierre ^c   Scarabin, Pierre Yves ^a   Bara, Lucienne ^d   Green, Fiona ^e   Cambien, François ^a  

^a INSERM   (France)

^b MONICA Project   (United Kingdom)

^c MONICA Projects ^*

^d SORBONNE UNIVERSITÉ   (France)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

coronary disease; fibrinogen; genetics; myocardial infarction

Indexed keywords

ADULT; ANGIOGRAPHY; ARTERIOSCLEROSIS; ARTICLE; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA FLANKING REGION; DNA POLYMORPHISM; FIBRINOGEN BLOOD LEVEL; GENOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 9044240867     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.3.440     Document Type: Article

References (37)

1. Smith EB, Keen GA, Grant A. Fate of fibrinogen in human arterial intima. Arteriosclerosis. 1990;10:263-275.
2. Gurewich V, Lipinski B, Hyde F. The effect of the fibrinogen concentration and the leucocyte count on intravascular fibrin deposition from soluble fibrin monomer complexes. Thromb Haemost. 1976;36:605-614.
3. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986;ii:533-537.
4. Wilhemsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984;311:501-505.
5. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease: the Framingham Study. JAMA. 1987;258:1183-1186.
6. Yarnell JWG, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, Elwood PC. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart diseases: the Caerphilly and Speedwell Collaborative Heart Disease Studies. Circulation. 1991;83:836-844.
7. Stone MC, Thorp JM. Plasma fibrinogen: a major coronary risk factor. J R Coll Gen Pract. 1985;35:565-569.
8. Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM study in healthy men. Arterioscler Thromb. 1994;14:54-59.
9. Qizilbash N, Jones L, Warlow C, Mann J. Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes. BMJ. 1991;303:605-609.
10. Smith WCS, Woodward M, Tunstall-Pedoe H. Intermittent claudication in Scotland. In: Fowkes FGR, ed. Epidemiology of Peripheral Vascular Disease. London, UK: Springer-Verlag; 1992:117-123.
11. Bara L, Nicaud V, Tiret L, Cambien F, Samama MM. Expression of a paternal history of premature myocardial infarction on fibrinogen, factor VIIc and PAI-1 in European offspring: the EARS Study. Thromb Haemost. 1994;71:434-440.
12. Chung DW, Harris JE, Davie EW. Nucleotide sequence of the 3 genes coding for human fibrinogen. In: Liu CY, Chien S, eds. Thrombosis, Coagulation and Fibrinolysis. New York, NY: Plenum Publishing Corporation; 1990:39-48.
13. Roy SN, Mukhopadhyay G, Redman CM. Regulation of fibrinogen assembly. J Biol Chem. 1990;265:6389-6393.
14. Huber P, Laurent M, Dalmon J. Human β-fibrinogen gene expression. J Biol Chem. 1990;265:5695-5701.
15. Humphries SE, Dubowitz M, Cook M, Stirling Y, Meade TW. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet. 1987;i:1452-1455.
16. Thomas AE, Green FR, Kelleher CH, Wilkes HC, Brennan PJ, Meade TW, Humphries SE. Variation in the promoter region of the β fibrinogen gene is associated with plasma fibrinogen levels in smokers and non smokers. Thromb Haemost. 1991;65:487-490.
17. Fowkes FGR, Connor JM, Smith FB, Wood J, Donnan PT, Lowe GDO. Fibrinogen genotype and risk of peripheral atherosclerosis. Lancet. 1992;339:693-696.
18. Scarabin PY, Bara L, Ricard S, Poirier O, Cambou JP, Arveiler D, Luc G, Evans AE, Samama M, Cambien F. Genetic variation at the β-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction: the ECTIM study. Arterioscler Thromb. 1993;13:886-891.
19. Parra HJ, Arveiler D, Evans AE, Cambou JP, Amouyel P, Bingham A, McMaster D, Schaffer P, Douste-Blazy P, Luc G, Richard JL, Ducimetiere P, Fruchart JC, Cambien F. A case-control study of lipoprotein particles in two populations at contrasting risk for CHD: the ECTIM Study. Arterioscler Thromb. 1992;12:701-707.
20. -1689 (AvaII) and BclI (β-fibrinogen) and TaqI (α-fibrinogen), and their detection by PCR. Hum Mutat. 1994;3:79-81.
21. Huber P, Dalmon J, Courtois G, Laurent M, Assouline Z, Marguerie G. Characterization of the 5′-flanking region for the human fibrinogen β gene. Nucleic Acids Res. 1987;15:1615-1625.
22. Saiki RK, Gefland DH, Stoffel S, Scahrf SJ, Higuchi R, Horn GT, Mullis KB, Herlich HA. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988;239: 487-491.
23. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single strand conformation polymorphisms. Proc Natl Acad Sci U S A. 1989;86:2766-2770.
24. Hayashi K. PCR-SSCP: a single sensitive method for detection of mutations in the genomic DNA. PCR Methods Appl. 1991;1:34-38.
25. Sanger F, Nicklen S, Coulson R. DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci U S A. 1977;74: 5463-5467.
26. Saiki RK. Genetic analysis of enzymatically amplified β globin and HLA-DQα genomic DNA with allele specific oligonucleotide probes. Nature. 1987;324:163-166.
27. Nei M. Molecular Evolutionary Genetics. New York, NY: Columbia University Press; 1987.
28. Baumann RE, Henschen AH. Human fibrinogen polymorphic site analysis by restriction endonuclease digestion and allele-specific polymerase chain reaction amplification: identification of polymorphisms at positions Aα312 and Bβ448. Blood. 1993;82: 2117-2124.
29. Dunning AM, Renges HH, Xu CF, Peacock R, Brasseur R, Laxer G, Tikkanen MJ, Bütler R, Saha N, Hamsten A, Rosseneu M, Talmud P, Humphries SE. Two amino acid substitutions in apolipoprotein B are in complete allelic association with the antigen group (x/y) polymorphism. Am J Hum Genet. 1991;50:208-221.
30. Lucassen AM, Julier C, Beressi JP, Boitard C, Froguel P, Lathrop M, Bell JI. Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR. Nat Genet. 1993;3:305-310.
31. Yarnell JWG, Fehily AM, Milbank J, Rubiki AJ, Eastham R, Hayes TRM. Determinants of plasma lipoproteins and coagulation factors in men from Caerphilly, South Wales. J Epidemiol Community Health. 1983;37:137-140.
32. Dalmon J, Laurent M, Courtois G. The human β fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element. Mol Cell Biol. 1993;13:1183-1193.
33. Baumann RE, Henschen AH. Genetic variation in the human Bβ fibrinogen gene promoter influences formation of a specific DNA-protein complex with the interleukin 6 response element. Thromb Haemost. 1993;69:961. Abstract.
34. Lane A, Humphries SE, Green FR. Effect on transcription of two common genetic polymorphisms adjacent to the promoter region of the β fibrinogen gene. Thromb Haemost. 1993;69:962. Abstract.
35. Green F, Hamsten A, Blombäck M, Humphries S. The role of β-fibrinogen genotypes in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemost. 1993;70:915-920.
36. Fuster V, Stein B, Ambrose JA, Badimon L, Badimon JJ, Chesebro JH. Atherosclerotic plaque rupture and thrombosis: evolving concepts. Circulation. 1990;82(suppl II):II-47-II-59.
37. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerosis plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.